» Articles » PMID: 34452026

COVID-19 Vaccine Hesitancy-A Scoping Review of Literature in High-Income Countries

Overview
Date 2021 Aug 28
PMID 34452026
Citations 235
Authors
Affiliations
Soon will be listed here.
Abstract

Vaccine hesitancy forms a critical barrier to the uptake of COVID-19 vaccine in high-income countries or regions. This review aims to summarize rates of COVID-19 hesitancy and its determinants in high-income countries or regions. A scoping review was conducted in Medline, Embase, CINAHL, and Scopus and was reported in accordance with the PRISMA-SCr checklist. The search was current as of March 2021. Studies which evaluated COVID-19 vaccine hesitancy and its determinants in high-income countries (US$12,536 or more GNI per capita in 2019) were included. Studies conducted in low, lower-middle, and upper-middle income countries or regions were excluded. Factors associated with vaccine hesitancy were grouped into four themes (vaccine specific, individual, group, or contextual related factors). Of 2237 articles retrieved, 97 articles were included in this review. Most studies were conducted in U.S. ( = 39) and Italy ( = 9). The rates of vaccine hesitancy across high-income countries or regions ranged from 7-77.9%. 46 studies (47.4%) had rates of 30% and more. Younger age, females, not being of white ethnicity and lower education were common contextual factors associated with increased vaccine hesitancy. Lack of recent history of influenza vaccination, lower self-perceived risk of contracting COVID-19, lesser fear of COVID-19, believing that COVID-19 is not severe and not having chronic medical conditions were most frequently studied individual/group factors associated with increased vaccine hesitancy. Common vaccine-specific factors associated with increased vaccine hesitancy included beliefs that vaccine are not safe/effective and increased concerns about rapid development of COVID-19 vaccines. Given the heterogeneity in vaccine hesitancy definitions used across studies, there is a need for standardization in its assessment. This review has summarized COVID-19 vaccine hesitancy determinants that national policymakers can use when formulating health policies related to COVID-19 vaccination.

Citing Articles

Modifiable risk factors of vaccine hesitancy: insights from a mixed methods multiple population study combining machine learning and thematic analysis during the COVID-19 pandemic.

Ebrahimi O, Sandbakken E, Moss S, Johnson S, Hoffart A, Bauermeister S BMC Med. 2025; 23(1):155.

PMID: 40075423 PMC: 11905715. DOI: 10.1186/s12916-025-03953-y.


Trust in official information as a key predictor of COVID-19 vaccine acceptance: evidence from a Czech longitudinal survey study.

Grygarova D, Kozeny J, Tisanska L, Havlik M, Horacek J BMC Public Health. 2025; 25(1):770.

PMID: 40001023 PMC: 11853922. DOI: 10.1186/s12889-025-21988-x.


Predictors of COVID-19 Vaccination Intention and Behavior Among Young People in a European Union Country With Low COVID-19 Vaccination Rates: Cross-Sectional Study.

Atanasova S, Kamin T, Perger N JMIR Public Health Surveill. 2025; 11:e64653.

PMID: 39983109 PMC: 11890135. DOI: 10.2196/64653.


Lessons for medical countermeasure development from unforeseen outbreaks.

Mura M, Trignol A, Le Dault E, Tournier J Emerg Microbes Infect. 2025; 14(1):2471035.

PMID: 39976365 PMC: 11894751. DOI: 10.1080/22221751.2025.2471035.


Adapting the Germ Defence Web-Based Intervention to Improve Infection Prevention and Control in Care Homes: Interview Study Among Care Home Staff.

Hall A, Aguilera-Munoz J, McGarrigle L, Eost-Telling C, Denison-Day J, Cabral C JMIR Form Res. 2025; 9:e66706.

PMID: 39970434 PMC: 11888083. DOI: 10.2196/66706.


References
1.
Fisher K, Bloomstone S, Walder J, Crawford S, Fouayzi H, Mazor K . Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults. Ann Intern Med. 2020; 173(12):964-973. PMC: 7505019. DOI: 10.7326/M20-3569. View

2.
Manning M, Gerolamo A, Marino M, Hanson-Zalot M, Pogorzelska-Maziarz M . COVID-19 vaccination readiness among nurse faculty and student nurses. Nurs Outlook. 2021; 69(4):565-573. PMC: 7862894. DOI: 10.1016/j.outlook.2021.01.019. View

3.
Schoch-Spana M, Brunson E, Long R, Ruth A, Ravi S, Trotochaud M . The public's role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States. Vaccine. 2020; 39(40):6004-6012. PMC: 7598529. DOI: 10.1016/j.vaccine.2020.10.059. View

4.
Schmelz K . Enforcement may crowd out voluntary support for COVID-19 policies, especially where trust in government is weak and in a liberal society. Proc Natl Acad Sci U S A. 2021; 118(1). PMC: 7817206. DOI: 10.1073/pnas.2016385118. View

5.
Bhopal S, Nielsen M . Vaccine hesitancy in low- and middle-income countries: potential implications for the COVID-19 response. Arch Dis Child. 2020; 106(2):113-114. DOI: 10.1136/archdischild-2020-318988. View